PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.\', \'Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA douglas.b.johnson@vumc.org.\', \'Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Cardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00093310.1136/jitc-2020-000933
?:doi
?:hasPublicationType
?:journal
  • Journal for immunotherapy of cancer
is ?:pmid of
?:pmid
?:pmid
  • 32434790
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.798
?:rankingScore_hIndex
  • 26
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 and immune checkpoint inhibitors: initial considerations.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32434790>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32434790>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all